5¿ù25ÀÏ : 3193 »çÀÌÆ®¸Ê °øÁö»çÇ× Æ®À§ÅÍ ¹Ù·Î°¡±â ¾à´ë´º½º Æ®À§ÅÍ ¹Ù·Î°¡±â ÇмúÇà»ç¾È³» Æ®À§ÅÍ ¹Ù·Î°¡±â  

³×ºñ°ÔÀ̼Ç

´ëÇмҰ³ ÇкΠ´ëÇпø ÀԽþȳ» ÀÚ·á¼¾ÅÍ ¾Ë¸²¸¶´ç

¾àÇבּ¸ÀÇ Áß½É

´º½ºÆ÷Ä¿½º¸¦ º¸½Ã·Á¸é Ç÷¡½Ã°¡ Áö¿øµÇ¾î¾ß ÇÕ´Ï´Ù.

±³³»¼Ò½Ä ¹Ù·Î°¡±â
05.09(¸ñ) ~ 05.15(¼ö)  
ÇÏ°è °èÀýÇб⠼ö°­½Åû  
05.21(È­)  
¼ö¾÷ÁÖ¼ö 3/4¼±  
05.29(¼ö) ~ 06.14(±Ý)  
Á¦2Çбâ ÀåÇлý ¼±Á¤ ½Åû¼­ Á¦Ãâ  
[05.23] 2013³â 2Çбâ ÀåÇÐ±Ý ½Åû ¾È³»...
[05.23] 2013Çг⵵ 1Çб⠺г³4Â÷ ¹× ¼ö¾÷¿¬ÇÑ...
[05.22] 2013Çг⵵ 1Çб⠺г³4Â÷ ¹× ±ÔÁ¤Çбâ...
[05.21] 2013Çг⵵ ÀÏÁÖÇмú¹®È­Àç´Ü ÇØ¿Ü ¹Ú»ç ...
[05.21] ´ë¿õÁ¦¾à ÀåÇлý ¼±¹ß ¾È³»
[05.21] [¾Ë¸²] 2013Çг⵵ ÇÏ°è °èÀýÇбâ 1Â÷...
[05.20] 2014Çг⵵ ¼­¿ï´ëÇб³¾àÇдëÇÐ ÀÔÇÐ ÀüÇü...
[05.15] (¼öÁ¤°øÁö/2Çгâ) ¹Ì±¹Áö¿ª¾à±¹ ½Ç¹«½Ç½À ...
 Àüâ´ö ±³¼ö ¼¼¹Ì³ª¾È³» (5/31)
 ±èÁ¾¿À ±³¼ö ¼¼¹Ì³ª¾È³» (5/29)
 ÀÓÇö¼® ±³¼ö ¼¼¹Ì³ª ¾È³»(5/28)
 Àüâ´ö ±³¼ö ¼¼¹Ì³ª¾È³» (5/31)
1. ÀÏ¡¡¡¡½Ã : 2013³â05¿ù31ÀÏ(±Ý) 12:00
2. Àå¡¡¡¡¼Ò : 142µ¿ °­´ç
3. ¿¬ »ç ¸í : Àüâ´ö ±³¼ö
4. °­¿¬Á¦¸ñ : IGSF4/CADM1 regulates T cell activation and homing

 ±èÁ¾¿À ±³¼ö ¼¼¹Ì³ª¾È³» (5/29)
1. ÀÏ¡¡¡¡½Ã : 2013³â05¿ù29ÀÏ(¼ö) ¿ÀÈÄ4½Ã30ºÐ
2. Àå¡¡¡¡¼Ò : 21µ¿ 227È£ ±³¼öȸÀǽÇ
3. ¿¬ »ç ¸í : ±èÁ¾¿À ±³¼ö
4. °­¿¬Á¦¸ñ : DUAL-DRUG LOADED NANOPARTICULATE SYSTEMS FOR ENHANCED CHEMOTHERAPY

 ÀÓÇö¼® ±³¼ö ¼¼¹Ì³ª ¾È³»(5/28)
1. ÀÏ¡¡¡¡½Ã : 2013³â05¿ù28ÀÏ(È­) 17½Ã
2. Àå¡¡¡¡¼Ò : 20µ¿ 422È£
3. ¿¬ »ç ¸í : Dr. Hyun-Suk Lim
4. °­¿¬Á¦¸ñ : Towards Targeting Protein-Protein Interfaces with Proteomimetics

ã¾Æ¿À½Ã´Â ±æÇлý»ýȰ »ó´ã¼¾ÅÍ